FARMINGTON, Conn., Aug. 29, 2012 /PRNewswire-iReach/ -- The biobanking market presents the largest of all opportunities in the area of new drug and treatment development for specific diseases. The global market for biobanking was $141 billion in 2010 and is projected to increase by 30% between 2010 and 2015, at a compound annual growth rate (CAGR) of 5.4%. Private sector biobanks will experience the greatest increase with growth of 64%, at a 5-year CAGR of 10.4% and it is expected to reach $69.6 billion by 2015. Population biobanks are projected to increase by 27%, at a CAGR of 5%, as additional population-based biobanks are formed in countries around the world. Disease-based biobanks are projected to increase by 6%, at a 5-year CAGR of 1.2%.
Leaders in Biobanking Congress 2012
October 1-2, 2012 | Chapel Hill, NC, USA
The 4th Annual Leaders in Biobanking Congress addresses both the business and science of biobanking. The conference brings together biomedical and biopharmaceutical researchers, regulators, biorepository managers and practitioners to investigate the best tactics for effective use of biospecimens within today's cutting edge research.
Attendees will gain insight from biobanking managers and biopreservation scientists and delve into the molecular advances in biomedical science; Determine best practices in biopreservation protocols through panel discussions; use case studies to analyze ongoing biobanking partnerships; attend interactive short courses; join discussion groups and network.
Attendees save up to $200 with Early Bird discount ending September 7, 2012.
|SOURCE Global Information, Inc.|
Copyright©2012 PR Newswire.
All rights reserved